UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 1/2013, Volume 56, Issue 2, pp. 195 - 203
Headache | Relapse | Vomiting | Mortality | Clinical trials | Hats | Children | Cerebrospinal fluid | ARTICLES AND COMMENTARIES | African trypanosomiasis | Trypanosome | human african trypanosomiasis | NECT | pharmacovigilance | Democratic Republic of Congo | safety | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Parasitic diseases | Pharmacology. Drug treatments | Protozoal diseases | Biological and medical sciences | Antiparasitic agents | Human protozoal diseases | Medical sciences | Trypanosomiasis | Antibiotics. Antiinfectious agents. Antiparasitic agents | Trypanosomiasis, African - drug therapy | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Child, Preschool | Eflornithine - adverse effects | Infant | Male | Treatment Outcome | Eflornithine - therapeutic use | Trypanosoma brucei gambiense | Young Adult | Medication Adherence | Nifurtimox - adverse effects | Adolescent | Adult | Female | Democratic Republic of the Congo | Drug Therapy, Combination | Child | Nifurtimox - therapeutic use | Cohort Studies | Patient safety | Pharmacology | Drug therapy | Medical treatment | Index Medicus | Side effects | Hospitals
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9683, pp. 56 - 64
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Parasitic diseases | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Trypanosomiasis | Trypanosomiasis, African - drug therapy | Trypanocidal Agents - adverse effects | Follow-Up Studies | Humans | Eflornithine - adverse effects | Male | Eflornithine - therapeutic use | Fever - chemically induced | Infection - chemically induced | Seizures - chemically induced | Trypanosomiasis, African - diagnosis | Trypanosomiasis, African - epidemiology | Congo - epidemiology | Adult | Female | Trypanocidal Agents - therapeutic use | Safety | Drug Therapy, Combination | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Trypanosoma brucei gambiense | Democratic Republic of the Congo - epidemiology | Animals | Nifurtimox - adverse effects | Infusions, Intravenous | Nifurtimox - therapeutic use | Evaluation | Drug therapy, Combination | Drug therapy | African trypanosomiasis | Drugs | Data analysis | Disease | Research methodology | Clinical trials | Clinical medicine | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
3.
Full Text
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Chemical reviews, ISSN 0009-2665, 11/2014, Volume 114, Issue 22, pp. 11305 - 11347
Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Trypanosomiasis - drug therapy | Humans | Drug Design | Antiprotozoal Agents - chemical synthesis | Leishmaniasis - drug therapy | Antiprotozoal Agents - chemistry | Antiprotozoal Agents - therapeutic use | Medical research | Disease | Drug therapy | Epidemiology | Index Medicus | Review
Journal Article
The Lancet (British edition), ISSN 0140-6736, 01/2018, Volume 391, Issue 10116, pp. 144 - 154
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Trypanosomiasis, African - drug therapy | Drug Administration Schedule | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Trypanosoma brucei gambiense | Nitroimidazoles - therapeutic use | Trypanosomiasis, African - diagnosis | Trypanosomiasis, African - mortality | Adult | Female | Trypanocidal Agents - therapeutic use | Democratic Republic of the Congo | Drug Therapy, Combination | Nifurtimox - therapeutic use | Vector-borne diseases | Drugs | Lymphatic system | Clinical trials | Parasites | Evidence-based medicine | Blood | Tropical diseases | Studies | Parasitic diseases | Drug therapy | Drug dosages | African trypanosomiasis | Index Medicus | Abridged Index Medicus
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 6, pp. 561 - 583
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Antiparasitic agents | General aspects | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Trypanosomiasis, African - drug therapy | Toxoplasmosis - drug therapy | Cestode Infections - drug therapy | Humans | Parasitic Diseases - drug therapy | Giardiasis - drug therapy | Leishmaniasis - drug therapy | Nematode Infections - drug therapy | Trematode Infections - drug therapy | Protozoan Infections - drug therapy | Antiparasitic Agents - therapeutic use | Amebiasis - drug therapy | Chagas Disease - drug therapy | Helminthiasis - drug therapy | Malaria - drug therapy | Antiprotozoal Agents - therapeutic use | Anthelmintics - therapeutic use | Drug Resistance | Complications and side effects | Dosage and administration | Drug therapy | Parasitic diseases | Patient outcomes | Index Medicus | Abridged Index Medicus | Symposium on Antimicrobial Therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2017, Volume 390, Issue 10110, pp. 2397 - 2409
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Endemic Diseases - statistics & numerical data | Trypanosomiasis, African - drug therapy | World Health Organization | Global Health | Risk Assessment | Humans | Male | Incidence | Travel | Animals | Trypanosomiasis, African - diagnosis | Neglected Diseases - diagnosis | Trypanosomiasis, African - epidemiology | Neglected Diseases - epidemiology | Female | Developing Countries | Trypanosoma brucei gambiense - isolation & purification | Endemic Diseases - prevention & control | Africa South of the Sahara - epidemiology | Travelers | Agricultural societies | Health aspects | Trypanosomiasis | World health | Vector-borne diseases | Drugs | Epidemics | Medical research | Rural areas | Medical treatment | Rural communities | Clinical trials | Parasites | Epidemiology | Disease control | Low level | Migrants | Tourists | Historical account | Parasitic diseases | Travellers | Differential diagnosis | African trypanosomiasis | Vaccines | Expatriates | Mammals | Exports | 20th century | Index Medicus | Abridged Index Medicus
Journal Article